Serious Game Intervention for Breast and Gynecologic Cancers
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help women with advanced breast and gynecologic cancers enhance their quality of life by teaching self-advocacy skills through a video game. The game, called Strong Together, allows users to make decisions for characters with similar cancer experiences, demonstrating the effects of self-advocacy. Participants will use the game to develop skills that can help manage symptoms and improve care. Women diagnosed with advanced cancer in the past six months and currently receiving non-curative treatment might be suitable for this trial. As a Phase 3 trial, it represents the final step before FDA approval, offering participants a chance to contribute to a potentially groundbreaking treatment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on using a video game to teach self-advocacy skills, so it's unlikely to require changes to your medication.
What prior data suggests that this serious game intervention is safe for women with advanced cancer?
Research has shown that the Strong Together game is practical and well-received by women with advanced breast or gynecologic cancer. Studies have found that participants generally respond positively to the game, which teaches self-advocacy skills. Players learn to better manage their symptoms and improve their quality of life. No major reports of negative effects have emerged from using the game, suggesting that Strong Together is a safe and well-tolerated option for those considering joining a trial.12345
Why are researchers excited about this trial?
Researchers are excited about the Strong Together serious game because it offers a unique, interactive approach to supporting patients with breast and gynecologic cancers. Unlike traditional methods that often involve medication or paper-based resources, this game is delivered on a tablet and aims to engage patients through gameplay, potentially enhancing emotional well-being and self-advocacy in a more engaging and relatable way. This digital intervention could complement existing treatments by providing an innovative, user-friendly tool for patient empowerment and education.
What evidence suggests that the Strong Together serious game is effective for teaching self-advocacy skills to women with advanced cancer?
Research has shown that the Strong Together game, which participants in this trial may receive, could benefit women with advanced breast or gynecologic cancer. Studies have found that participants find the game easy to use and well-received. It teaches self-advocacy skills, which can enhance quality of life and reduce symptoms. The game places users in situations where they make choices and see the results of speaking up for themselves. It also provides feedback to help users learn and apply these skills in real life. Overall, early evidence suggests it could be a useful tool for managing the challenges of living with cancer.12367
Are You a Good Fit for This Trial?
This trial is for women over 18 with advanced breast or gynecologic cancer, who can read and write in English, have a life expectancy of at least 6 months, and are not on hospice care or have unstable mental health disorders. They should be able to perform daily activities with minimal assistance.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage with the Strong Together serious game intervention to learn self-advocacy skills
Follow-up
Participants are monitored for changes in self-advocacy, symptom burden, and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Enhanced Care as Usual
- Strong Together serious game
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Cancer Institute (NCI)
Collaborator